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Summary  Streptococcus  agalactiae  (S.  agalactiae), also  referred  as  group  B  strep-
tococcus  (GBS),  is  an  important  pathogen  in  neonates  and  a  rare  cause  of  invasive
infection  in  adults.  It  is  well  known  that  GBS  endocarditis  is  a  virulent  infection  that
can  cause  serious  complications.  The  overall  mortality  rate  remains  high  despiteGBS;
Infective  endocarditis;
Vegetation
surgical  treatment.  We  describe  a  case  of  native  mitral  valve  endocarditis  caused
by  GBS  in  an  86-year-old  woman  treated  medically.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
.
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istory
n  86-year-old  female  presented  to  our  hospi-
al complaining  of  chills,  excessive  sweating  and
 feeling  of  general  sickness  that  had  persisted
or two  days.  The  patient  did  not  complain
f chest  pain,  shortness  of  breath,  coughing  or
eadache.  Past  medical  history  showed  signiﬁ-
ant degenerative  calciﬁc  mitral  valve  disease
ith moderate  mitral  regurgitation  and  endome-
rial cancer,  which  was  treated  with  an  abdominal
urgical resection  followed  by  radiation  therapy.
ostoperative care  was  complicated  by  multiple
ntra-abdominal abscesses.  The  patient  also  had  a
∗ Corresponding author at: Conemaugh Memorial Medical Cen-
er, E3 Building, 1086 Franklin Street, Johnstown, PA 15905, USA.
ax: +1 814 534 3290.
E-mail address: mabdelgh@conemaugh.org (M. Abdelghany).
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876-0341/© 2014 King Saud Bin Abdulaziz University for Health Scierior  history  of  frequent  intestinal  obstruction  and
adiation enteritis,  which  was  treated  surgically  4
onths before  the  visit.
hysical  examination
n admission,  the  patient  had  a temperature
f 39.1 ◦C (102.4 ◦F),  a  heart  rate  of 92/min,
espiratory rate  of  20/min,  blood  pressure  of
20/80  mmHg  and  oxygen  saturation  of  97%  in  room
ir. Heart  auscultation  revealed  a holosystolic  mur-
ur at  the  cardiac  apex  radiating  to  the  left  axilla.
nvestigations
aboratory  studies  revealed  a  white  blood  cell
ount  of  13,000/mm3 with  88%  neutrophils  and
% bands.  The  erythrocyte  sedimentation  rate
as 36  mm/h,  troponin  0.22  ng/ml  and  lactic  acid
.5 mmol/l.  Two  blood  cultures  were  drawn  from
wo different  sites  30  min  apart  followed  by  empiric
nces. Published by Elsevier Ltd. All rights reserved.
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treatment  with  ceftriaxone  1 g  IV  and  azithromycin
500 mg  IV.  EKG  showed  a  normal  sinus  rhythm.
On the  ﬁrst  day  of  admission,  the  two  blood
cultures were  positive  for  gram-positive  cocci,
suggesting streptococcus.  On  the  second  day  of  hos-
pitalization,  GBS  was  identiﬁed  and  found  to  be
penicillin-sensitive,  and  the  patient  was  switched
to penicillin  G.  No  further  characterization  of  this
GBS was  performed.  Transthoracic  echocardiogra-
phy (TTE)  showed  a  mobile  valvular  vegetation  on
the posterior  mitral  leaﬂet  measuring  2.0  cm  in  size
and increased  severity  of  mitral  regurgitation  com-
pared with  an  echocardiogram  performed  4  months
earlier.  A  CT  scan  of  the  head  did  not  show  any  acute
intracranial  abnormalities.
Diagnosis
The  patient  fulﬁlled  the  diagnosis  of  deﬁnite
endocarditis with  one  major  criterion  (abnormal
echocardiogram)  and  two  minor  criteria  (body  tem-
perature  higher  than  38 ◦C  and  predisposing  heart
condition).
Treatment
Antibiotic  therapy  combined  with  mitral  valve
replacement was  recommended  to  the  patient.
However, the  patient  refused  and  requested
medical treatment  alone.  A  transthoracic  echocar-
diogram  performed  again  on  the  ﬁfth  day  of
hospitalization showed  that  the  vegetation  had
increased  in  size  to  2.15  cm.  A  peripherally  inserted
central catheter  (PICC)  line  was  placed  and  the
patient  was  treated  with  IV  penicillin  G  for  4  weeks.
The patient  completed  the  four-week  course  of
penicillin  uneventfully  without  any  complication.
The patient  continued  to  be  asymptomatic  9
months after  treatment.
Discussion
Streptococcus  agalactiae  is  a  rare  cause  of  endo-
carditis in  adults  [1].  Diabetes  mellitus,  malignancy,
HIV  infection,  alcoholism,  cardiovascular  disease
and  advanced  hepatic  and  renal  disease  have  been
identiﬁed  as  risk  factors  for  GBS  endocarditis  [2—4].
Transesophageal  echocardiography  is  more  sensi-
tive than  transthoracic  echocardiography  and  is
the preferred  approach  when  transthoracic  imaging
windows  are  limited  [5]. GBS  infective  endocardi-
tis may  be  complicated  by  major  emboli  [2,6].
The development  of  emboli  was  observed  in  50%
of patients  in  one  series,  most  commonly  in  the
brain  (7  patients;  23%)  [3].  The  frequency  of  emboliM.  Abdelghany,  L.  Schenfeld
robably  relates  to  the  large  size  and  the  friability
f the  vegetations,  which  appear  to  be  character-
stics of  group  B  streptococcus  endocarditis  [1].
he case  fatality  rate  of  invasive  GBS  infections
mong adults  was  estimated  to  be  approximately
4% [4,7]. Penicillin  G  remains  the  drug  of  choice
or such  conditions.  It  is  unclear  whether  the  addi-
ion of  gentamicin  during  the  ﬁrst  two  weeks  of
herapy  is  necessary  [1]. Vancomycin  remains  the
nitial treatment  of  choice  for  GBS  infection  in
atients who  are  allergic  to  penicillin.  Because  of
he severity  of  the  S.  agalactiae  infection,  several
uthors  recommend  both  early  medical  and  surgical
reatment  [1,8]. Siciliano  et  al.  [8]  reported  better
utcomes  with  surgical  treatment  within  the  ﬁrst
eek of  endocarditis  diagnosis.  However,  favorable
utcomes  have  also  been  described  after  conser-
ative medical  treatment  with  antibiotics  alone
9,10]. Although  our  patient  was  an  obvious  can-
idate  for  surgical  treatment  due  to  the  size  of the
egetation  and  worsening  mitral  regurgitation,  she
efused any  surgical  intervention.
ummary
BS  endocarditis  is  an  invasive  infection  that  has
een increasingly  reported  recently.  It is  evident
hat group  B  streptococcus  endocarditis  is a  viru-
ent disease  compared  with  endocarditis  caused  by
ther streptococci  and  is  as  virulent  as  Staphylococ-
us aureus  [1]. Complications  such  as  embolization,
articularly in  the  brain,  heart  failure  and  signiﬁ-
ant mortality  have  been  reported  [7]. Antibiotic
herapy combined  with  surgery  has  been  recom-
ended by  many  authors.  However,  other  reported
ases  were  successfully  managed  with  medical
reatment alone.  We  presented  a case  of  GBS  of
ative mitral  valve  endocarditis  in  an  old  immuno-
ompromised patient  who  was  successfully  treated
edically  with  antibiotic  therapy.
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